Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Valente

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 30, 2020
Metastatic disease in head & neck oncologyPaolo Pisani, Mario Airoldi, Anastasia Allais, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 30, 2020
Metastatic disease in head & neck oncologyPaolo Pisani, Mario Airoldi, Anastasia Allais, et al.
Pageof 8